---
title: "KRBP.US (KRBP.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KRBP.US/news.md"
symbol: "KRBP.US"
name: "KRBP.US"
parent: "https://longbridge.com/en/quote/KRBP.US.md"
datetime: "2026-03-05T10:35:58.784Z"
locales:
  - [en](https://longbridge.com/en/quote/KRBP.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KRBP.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KRBP.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/KRBP.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/KRBP.US/news.md)


# KRBP.US (KRBP.US) — Related News

### [Kiromic BioPharma ($KRBPQ) Is Paying a $2.3M Settlement to Investors — Here’s How to Get Your Share](https://longbridge.com/en/news/260086780.md)
*2025-10-06T18:24:24.000Z*
> Kiromic BioPharma ($KRBPQ) has agreed to pay a $2.3 million settlement to investors over its 2021 IPO. Eligible claimant

### [Kiromic Biopharma, Inc. SEC 10-K Report](https://longbridge.com/en/news/228396962.md)
*2025-02-14T21:18:01.000Z*
> Kiromic Biopharma, Inc. has released its annual 10-K report detailing its financial performance and business operations.

### [Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'](https://longbridge.com/en/news/225405302.md)
*2025-01-17T22:36:59.000Z*
> Jan 17 (Reuters) - Kiromic Biopharma (KRBP.PK) :* KIROMIC BIOPHARMA INC -APPLIED TO LIST COMMON STOCK ON THE NYSE AMERIC

### [Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation | KRBP Stock News](https://longbridge.com/en/news/221309406.md)
*2024-12-03T16:02:00.000Z*
> Kiromic BioPharma, Inc. has settled an SEC investigation regarding the non-disclosure of clinical holds on its IND appli

### [Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation](https://longbridge.com/en/news/214696283.md)
*2024-09-19T12:53:09.000Z*
> Sept 19 (Reuters) - Kiromic Biopharma Inc (KRBP.PK) :* KIROMIC BIOPHARMA: ADVANCES DELTACEL-01 INTO EXPANSION PHASE FOLL

### [Kiromic BioPharma's Deltacel-01 Phase 1 Trial Shows Early Efficacy At Sixth Week](https://longbridge.com/en/news/205101779.md)
*2024-05-29T13:14:51.000Z*
> Kiromic BioPharma's Deltacel-01 Phase 1 trial shows favorable safety, tolerability, and early efficacy in patients with 

### [Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site](https://longbridge.com/en/news/204465486.md)
*2024-05-20T12:59:40.000Z*
> May 20 (Reuters) - Kiromic Biopharma Inc (KRBP.PK) :* KIROMIC BIOPHARMA ADDS UPMC AS FOURTH DELTACEL-01 CLINICAL TRIAL S

### [Kiromic BioPharma Reports Favorable Safety, Tolerability, And Early Efficacy From Third Patient In Deltacel-01 Clinical Trial](https://longbridge.com/en/news/201170411.md)
*2024-04-02T14:10:45.000Z*
> April 2 (Reuters) - Kiromic BioPharma Inc (KRBP.PK) :* KIROMIC BIOPHARMA REPORTS FAVORABLE SAFETY, TOLERABILITY, AND EAR

### [Kiromic BioPharma Announces First Patient Dosed In Phase 1 Study Evaluating Deltacel](https://longbridge.com/en/news/104366957.md)
*2023-12-14T13:31:10.000Z*
> Dec 14 (Reuters) - Kiromic Biopharma Inc (KRBP.PK) :* KIROMIC BIOPHARMA ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 STUDY E